K883714 is an FDA 510(k) clearance for the QM300 APOLIPOPROTEIN B ANTIBODY PACK. Classified as Apolipoproteins (product code MSJ), Class I - General Controls.
Submitted by Kallestad Diag, A Div. of Erbamont, Inc. (Chaska, US). The FDA issued a Cleared decision on October 19, 1988 after a review of 50 days - a notably fast clearance cycle.
This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1475 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Kallestad Diag, A Div. of Erbamont, Inc. devices